Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00899782
Official study title

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Study summary

This research studies collecting and storing tissue and blood samples from patients with lung cancer who are undergoing surgery. Collecting and storing samples of tissue and blood from patients with lung cancer to study in the laboratory may help doctors learn more about changes that may occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedcytology specimen collection procedure

The study team can explain what participation involves.

Who it may be forLung Carcinoma · Lung Neoplasm

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 3, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?19 U.S. locations

Locations may change over time.

Who runs it?Alliance for Clinical Trials in Oncology

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Alliance for Clinical Trials in Oncology
Interventions being studied
Other: cytology specimen collection procedure
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Surgery→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Histologic Documentation: All patients with suspected or histologically documented previously untreated lung cancer undergoing surgical resection are eligible whether or not the patient participates in a CALGB-sponsored treatment trial; patients enrolled on a CALGB trial of preoperative chemotherapy for lung cancer will be eligible if a pre-treatment frozen sample of tumor (e.g., a positive lymph node from mediastinoscopy) can be submitted to the bank; patients enrolled on CALGB 140203, intraoperative sentinel node mapping in non-small cell lung cancer, are not eligible. 2. No patients with known infectious disease, such as human immunodeficiency virus (HIV), tuberculosis (TB), or hepatitis B, C

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Tunnell Cancer Center at Beebe Medical CenterLewes, Delaware
  • CCOP - Christiana Care Health ServicesNewark, Delaware
  • Union Hospital of Cecil CountyElkton, Maryland
  • Dana-Farber/Brigham and Women's Cancer CenterBoston, Massachusetts
  • Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer InstituteBoston, Massachusetts
  • Masonic Cancer Center at University of MinnesotaMinneapolis, Minnesota
  • Ellis Fischel Cancer Center at University of Missouri - ColumbiaColumbia, Missouri
  • Siteman Cancer Center at Barnes-Jewish Hospital - Saint LouisSt Louis, Missouri
  • Cancer Institute of New Jersey at Cooper - VoorheesVoorhees Township, New Jersey
  • Roswell Park Cancer InstituteBuffalo, New York
  • SUNY Upstate Medical University HospitalSyracuse, New York
  • Veterans Affairs Medical Center - AshevilleAsheville, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 3, 2022. Always confirm current availability with the study team.

View original record ↗